Biggest News Aggregation in the World
📰 Solid Biosciences Inc News

Page 4 - Solid Biosciences Inc News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Solid Biosciences Inc. Real-time updates on events, politics, business and more.

Comparing Finch Therapeutics Group (NASDAQ:FNCH) and Solid Biosciences (NASDAQ:SLDB)

Solid Biosciences (NASDAQ:SLDB – Get Free Report) and Finch Therapeutics Group (NASDAQ:FNCH – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk. Profitability This table compares Solid Biosciences […]
United States Skysong Innovations Finch Therapeutics Group Ultragenyx Pharmaceutical Inc University Of Minnesota Solid Biosciences Inc

Why CorMedix Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket - ReAlpha Tech Corp (NASDAQ:AIRE), AgileThought (NASDAQ:AGIL)

Shares of CorMedix Inc. (NASDAQ: CRMD) surged in pre-market trading as the company posted a narrower-than-expected third-quarter loss. Cormedix posted a loss of 17 cents per share for the third quarter, versus market expectations for a loss of 21 cents per share.
Realpha Tech Corp Arcturus Therapeutics Holdings Inc Intrusion Inc Heron Therapeutics Inc Momentus Inc Electriq Power Holdings Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Solid Biosciences Inc. (NASDAQ:SLDB) Sees Significant Decrease in Short Interest

Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) was the target of a large decrease in short interest in the month of October. As of October 15th, there was short interest totalling 21,500 shares, a decrease of 27.4% from the September 30th total of 29,600 shares. Based on an average trading volume of 23,700 shares, […]
United States Solid Biosciences Inc Prudential Financial Inc Charles Schwab Investment Management Inc Atria Wealth Solutions Inc Cantor Fitzgerald

Pompe Disease Market to Exhibit Significant Growth by 2032, Predicts DelveInsight | Leading Companies - Asklepios Biopharmaceutical, Inc., Astellas Pharma Inc., Amicus Therapeutics, Sanofi, Spark Therapeutics

/PRNewswire/ -- DelveInsights Pompe Disease Market Insights report includes a comprehensive understanding of current treatment practices, Pompe disease...
United Kingdom United States Reveragen Biopharma Hansa Biopharma Pompe Diseasetherapies Shruti Thakur

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science